Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Hims & Hers Health, Inc. HIMS
$10.71
+$0.14 (1.28%)
На 18:03, 12 мая 2023
-40.90%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
2223950498.00000000
-
week52high
12.34
-
week52low
2.72
-
Revenue
526916000
-
P/E TTM
-38
-
Beta
0.46075700
-
EPS
-0.32000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Outperform | Outperform | 10 авг 2022 г. |
| SVB Leerink | Underperform | Underperform | 09 авг 2022 г. |
| SVB Leerink | Underperform | 15 июл 2022 г. | |
| Piper Sandler | Overweight | Overweight | 26 мая 2022 г. |
| Citigroup | Buy | Buy | 10 мая 2022 г. |
| Truist Securities | Hold | 07 сент 2022 г. | |
| Piper Sandler | Neutral | Overweight | 17 окт 2022 г. |
| SVB Leerink | Market Perform | Underperform | 08 ноя 2022 г. |
| B of A Securities | Buy | Neutral | 08 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Boughton Soleil | D | 237089 | 50000 | 31 янв 2023 г. |
| Boughton Soleil | D | 287089 | 2000 | 17 янв 2023 г. |
| Boughton Soleil | D | 289089 | 12345 | 03 янв 2023 г. |
| O'Keefe Lynne Chou | D | 0 | 10044 | 19 дек 2022 г. |
| Becklund Irene | D | 11241 | 6445 | 19 дек 2022 г. |
| Boughton Soleil | D | 301434 | 13744 | 19 дек 2022 г. |
| Boughton Soleil | D | 315178 | 4837 | 16 дек 2022 г. |
| Becklund Irene | D | 32074 | 2291 | 15 дек 2022 г. |
| Becklund Irene | D | 52251 | 4019 | 15 дек 2022 г. |
| Becklund Irene | D | 24327 | 1871 | 15 дек 2022 г. |
Новостная лента
Hims & Hers: Profitability Pulled Forward
Seeking Alpha
25 янв 2023 г. в 15:29
Hims & Hers pulled forward its profitability. HIMS is now expected to be EBITDA profitable in Q4 2022, months ahead of schedule.
Hims & Hers Health: Buy Into The Strong Growth Momentum
Seeking Alpha
18 янв 2023 г. в 05:35
Telehealth is gaining strong adoption momentum amongst younger generations. HIMS has a very attractive business model.
Top Wall Street analysts like these stocks amid easing inflation
CNBC
15 янв 2023 г. в 07:27
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, including Alphabet & Intuitive Surgical
Hims & Hers Health: The Ultimate Pick For 2023
Seeking Alpha
23 дек 2022 г. в 15:52
Hims & Hers Health is a telehealth company which solves two major issues for patients in modern healthcare: it provides easier access to physicians and lower cost treatments. Hims is growing at a blistering pace and the company is expected to be EBIT positive for the first time in Q4 2022 and recently made a new 52-week high.
Hims & Hers Health: The Unicorn (Former) SPAC For 2023
Seeking Alpha
16 дек 2022 г. в 19:04
Hims & Hers Health, Inc. blew their original 2022 financial projections out of the water. The company is a growth investor's dream: large TAM, predictable subscription revenue, tech-company margins, and soon-to-come free cash flow.